Type 2

The Cureus Journal of Medical ScienceSodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Risk of Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsSodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as a transformative therapy in type 2 diabetes mellitus (T2DM),….18 hours ago

News Source0195 views

The Cureus Journal of Medical ScienceSodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Risk of Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsSodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as a transformative therapy in type 2 diabetes mellitus (T2DM),….18 hours ago

Related posts

WVU Medicine endocrinologist highlights steps to prevent and manage diabetes

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Dexcom unveils Type 2 diabetes CGM data at ATTD